Prognostic value of programmed death ligand-1 and programmed death-1 expression in patients with upper tract urothelial carcinoma.

Campedel L, Compérat E, Cancel-Tassin G, Varinot J, Pfister C, Delcourt C, Gobet F, Roumiguié M, Patard PM, Daniel G, Bigot P, Carrouget J, Eymerit C, Larré S, Léon P, Durlach A, Ruffion A, de Mazancourt ES, Decaussin-Petrucci M, Bessède T, Lebacle C, Ferlicot S, Robert G, Vuong NS, Philip M, Crouzet S, Matillon X, Mège-Lechevallier F, Lang H, Mouracade P, Lindner V, Gougis P, Cussenot O, Rouprêt M, Seisen T

Open source

DOI
10.1111/bju.16129
Published
2023 Nov
Container
BJU international
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bju.16129,
  title = {Prognostic value of programmed death ligand-1 and programmed death-1 expression in patients with upper tract urothelial carcinoma.},
  author = {Campedel L and Compérat E and Cancel-Tassin G and Varinot J and Pfister C and Delcourt C and Gobet F and Roumiguié M and Patard PM and Daniel G and Bigot P and Carrouget J and Eymerit C and Larré S and Léon P and Durlach A and Ruffion A and de Mazancourt ES and Decaussin-Petrucci M and Bessède T and Lebacle C and Ferlicot S and Robert G and Vuong NS and Philip M and Crouzet S and Matillon X and Mège-Lechevallier F and Lang H and Mouracade P and Lindner V and Gougis P and Cussenot O and Rouprêt M and Seisen T},
  year = {2023},
  journal = {BJU international},
  doi = {10.1111/bju.16129},
  url = {https://doi.org/10.1111/bju.16129}
}

RIS

TY  - JOUR
TI  - Prognostic value of programmed death ligand-1 and programmed death-1 expression in patients with upper tract urothelial carcinoma.
AU  - Campedel L
AU  - Compérat E
AU  - Cancel-Tassin G
AU  - Varinot J
AU  - Pfister C
AU  - Delcourt C
AU  - Gobet F
AU  - Roumiguié M
AU  - Patard PM
AU  - Daniel G
AU  - Bigot P
AU  - Carrouget J
AU  - Eymerit C
AU  - Larré S
AU  - Léon P
AU  - Durlach A
AU  - Ruffion A
AU  - de Mazancourt ES
AU  - Decaussin-Petrucci M
AU  - Bessède T
AU  - Lebacle C
AU  - Ferlicot S
AU  - Robert G
AU  - Vuong NS
AU  - Philip M
AU  - Crouzet S
AU  - Matillon X
AU  - Mège-Lechevallier F
AU  - Lang H
AU  - Mouracade P
AU  - Lindner V
AU  - Gougis P
AU  - Cussenot O
AU  - Rouprêt M
AU  - Seisen T
PY  - 2023
JO  - BJU international
DO  - 10.1111/bju.16129
UR  - https://doi.org/10.1111/bju.16129
ER  - 

APA

L, C., E, C., G, C., J, V., C, P., C, D., F, G., M, R., PM, P., G, D., P, B., J, C., C, E., S, L., P, L., A, D., A, R., ES, D. M., M, D., T, B., C, L., S, F., G, R., NS, V., M, P., S, C., X, M., F, M., H, L., P, M., V, L., P, G., O, C., M, R., & T, S. (2023). Prognostic value of programmed death ligand-1 and programmed death-1 expression in patients with upper tract urothelial carcinoma.. BJU international. https://doi.org/10.1111/bju.16129

Source records